HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Cyclin-Dependent Kinase Inhibitor p18

An INK4 cyclin-dependent kinase inhibitor containing five ANKYRIN-LIKE REPEATS. Aberrant expression of this protein has been associated with deregulated EPITHELIAL CELL growth, organ enlargement, and a variety of NEOPLASMS.
Also Known As:
CDK6-Associated Protein p18; CDKN2C Protein; Cyclin-Dependent Kinase Inhibitor 2C; INK4C Protein; p18 CDK6 Inhibitor; p18INK4c Protein; CDK6 Associated Protein p18; CDK6 Inhibitor, p18; Cyclin Dependent Kinase Inhibitor 2C; Cyclin Dependent Kinase Inhibitor p18; p18, CDK6-Associated Protein
Networked: 7 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Pashenkov, Mikhail: 1 article (11/2012)
2. Fisher, David E: 1 article (11/2012)
3. Stingl, Georg: 1 article (11/2012)
4. Golub, Todd R: 1 article (11/2012)
5. Mertz, Kirsten D: 1 article (11/2012)
6. Jalili, Ahmad: 1 article (11/2012)
7. Pathria, Gaurav: 1 article (11/2012)
8. Wagner, Stephan N: 1 article (11/2012)
9. Brunet, Jean-Philippe: 1 article (11/2012)
10. Wagner, Christine: 1 article (11/2012)

Related Diseases

1. Neoplasms (Cancer)
2. Melanoma (Melanoma, Malignant)
3. Pituitary Neoplasms (Pituitary Adenoma)
4. Multiple Myeloma
5. Hyperplasia

Related Drugs and Biologics

1. Cyclins
2. Phosphotransferases (Kinase)
3. Adrenocorticotropic Hormone (ACTH)